GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma

肝细胞癌 索拉非尼 癌症研究 医学 内科学 化学
作者
Shiwen Ma,Fei Xie,Xiaohu Wen,Yao Mawulikplimi Adzavon,Ruping Zhao,Jinyi Zhao,Han Li,Yanqi Li,Jingtao Liu,Chen Liu,Yi Yang,Pengxiang Zhao,Boqing Wang,Wei Zhao,Xuemei Ma
出处
期刊:Pharmacological Research [Elsevier]
卷期号:210: 107490-107490
标识
DOI:10.1016/j.phrs.2024.107490
摘要

The emergence of sorafenib resistance has become a predominant impediment and formidable dilemma in the therapeutic approach for hepatocellular carcinoma (HCC). Although the approval of next-generation drugs as alternatives to sorafenib is a significant development, the concurrent use of inhibitors that target additional key molecular pathways remains an effective strategy to mitigate the acquisition of resistance. Here, we identified Glutathione S-Transferase Alpha 1 (GSTA1) as a critical modulator of sorafenib resistance (SR) in hepatocellular carcinoma (HCC) based on our findings from experiments conducted on recurrent liver cancer tissues, xenograft mouse models, organoids, and sorafenib-resistant cells. Elevated GSTA1 levels are strongly associated with adverse clinical prognoses. The knockout of GSTA1 reinstates sorafenib sensitivity, whereas its overexpression attenuates drug efficacy. Mechanistically, GSTA1 enhances the accumulation of lipid peroxides and suppresses ferroptosis by exerting its peroxidase function to regulate the SR. Notably, the upregulation of GSTA1 expression is mediated by the transcription factor CTNNB1 (β-catenin), resulting in the formation of a cytoplasmic complex between GSTA1 and CTNNB1. This complex facilitates the nuclear translocation of CTNNB1, establishing a positive feedback loop. The combined use of GSTA1 and CTNNB1 inhibitors demonstrated synergistic anti-tumour effects through the induction of ferroptosis both in vitro and in vivo. Our findings reveal a novel regulatory role of the GSTA1/CTNNB1 axis in ferroptosis, suggesting that targeting GSTA1 and CTNNB1 could be a promising strategy to circumvent sorafenib resistance in HCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
星星给星星的求助进行了留言
刚刚
嘿嘿嘿完成签到,获得积分10
1秒前
星月夜应助Jieh采纳,获得20
1秒前
limbo完成签到 ,获得积分10
1秒前
万能图书馆应助wyuan526采纳,获得10
2秒前
3秒前
蹦极辣条完成签到,获得积分20
4秒前
研友_VZG7GZ应助三度和弦采纳,获得10
4秒前
decade完成签到,获得积分10
5秒前
5秒前
77seven完成签到,获得积分10
6秒前
念所三旬发布了新的文献求助10
8秒前
研友_Zza3qn完成签到 ,获得积分10
8秒前
decade发布了新的文献求助10
8秒前
9秒前
10秒前
10秒前
10秒前
霸气绿草完成签到,获得积分20
11秒前
13秒前
科研小虫应助进击的研狗采纳,获得10
13秒前
科目三应助vn采纳,获得10
13秒前
14秒前
CodeCraft应助火龙果采纳,获得10
14秒前
15秒前
15秒前
个性的紫菜应助长情中蓝采纳,获得30
17秒前
霸气绿草发布了新的文献求助10
18秒前
NexusExplorer应助大方小懒猪采纳,获得10
19秒前
小二郎应助科研通管家采纳,获得10
20秒前
bkagyin应助科研通管家采纳,获得10
20秒前
酷波er应助科研通管家采纳,获得10
20秒前
在水一方应助科研通管家采纳,获得10
20秒前
所所应助科研通管家采纳,获得10
20秒前
斯文败类应助科研通管家采纳,获得10
21秒前
小蘑菇应助科研通管家采纳,获得10
21秒前
华仔应助科研通管家采纳,获得10
21秒前
科研通AI2S应助科研通管家采纳,获得10
21秒前
21秒前
21秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Very-high-order BVD Schemes Using β-variable THINC Method 850
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3252120
求助须知:如何正确求助?哪些是违规求助? 2894918
关于积分的说明 8284229
捐赠科研通 2563608
什么是DOI,文献DOI怎么找? 1391769
科研通“疑难数据库(出版商)”最低求助积分说明 651925
邀请新用户注册赠送积分活动 628951